Amy Jackson-Fisher

1.0k total citations
21 papers, 652 citations indexed

About

Amy Jackson-Fisher is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Amy Jackson-Fisher has authored 21 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Amy Jackson-Fisher's work include HER2/EGFR in Cancer Research (8 papers), Cancer Cells and Metastasis (5 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Amy Jackson-Fisher is often cited by papers focused on HER2/EGFR in Cancer Research (8 papers), Cancer Cells and Metastasis (5 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Amy Jackson-Fisher collaborates with scholars based in United States, Spain and Switzerland. Amy Jackson-Fisher's co-authors include David F. Stern, Martin Gassmann, Kathleen Mathers, Jon P. Golding, Gary Bellinger, B. Franklin Pugh, Rajani Ramabhadran, Jacqueline K. Morris, Kuo‐Fen Lee and Eric L. Powell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Amy Jackson-Fisher

21 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Jackson-Fisher United States	13	358	346	121	76	71	21	652
Sergio Anastasi Italy	11	470 1.3×	259 0.7×	92 0.8×	61 0.8×	81 1.1×	12	709
Jennifer L. Gilmore United States	11	311 0.9×	295 0.9×	125 1.0×	27 0.4×	89 1.3×	13	582
Bhavani S. Kowtharapu Germany	15	368 1.0×	153 0.4×	107 0.9×	41 0.5×	46 0.6×	27	684
Rong-Hua Tao United States	12	430 1.2×	152 0.4×	117 1.0×	41 0.5×	34 0.5×	17	648
Árpád Szöőr Hungary	15	279 0.8×	467 1.3×	101 0.8×	116 1.5×	30 0.4×	58	774
Sarah Bhargava Germany	9	343 1.0×	298 0.9×	40 0.3×	28 0.4×	49 0.7×	12	590
Nathalie Kersual France	7	340 0.9×	227 0.7×	45 0.4×	98 1.3×	47 0.7×	9	570
Marie-Claire Wagle United States	8	547 1.5×	173 0.5×	41 0.3×	143 1.9×	101 1.4×	13	790
Delphine Goehrig France	13	362 1.0×	284 0.8×	44 0.4×	58 0.8×	68 1.0×	20	697
H. Carl Le United States	8	614 1.7×	310 0.9×	43 0.4×	65 0.9×	41 0.6×	10	824

Countries citing papers authored by Amy Jackson-Fisher

Since Specialization

Citations

This map shows the geographic impact of Amy Jackson-Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Jackson-Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Jackson-Fisher more than expected).

Fields of papers citing papers by Amy Jackson-Fisher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Jackson-Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Jackson-Fisher. The network helps show where Amy Jackson-Fisher may publish in the future.

Co-authorship network of co-authors of Amy Jackson-Fisher

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Jackson-Fisher. A scholar is included among the top collaborators of Amy Jackson-Fisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Jackson-Fisher. Amy Jackson-Fisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ram, Sripad, Pamela Whalen, Shibing Deng, et al.. (2021). Pixelwise H-score: A novel digital image analysis-based metric to quantify membrane biomarker expression from immunohistochemistry images. PLoS ONE. 16(9). e0245638–e0245638. 33 indexed citations

Maitland, Michael L., Jasgit C. Sachdev, Manish Sharma, et al.. (2021). First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody–Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors. Clinical Cancer Research. 27(16). 4511–4520. 63 indexed citations

Arend, Rebecca C., Amy Jackson-Fisher, Ira Jacobs, Jeffrey Chou, & Bradley J. Monk. (2021). Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease. Cancer Biology & Therapy. 22(2). 89–105. 25 indexed citations

Whalen, Pamela, Amy Jackson-Fisher, Cory L. Painter, et al.. (2019). Abstract 4925: Development of a novel PTK7 immunohistochemistry (IHC) assay and analytical validation in epithelial malignancies of lung, breast and ovary. Cancer Research. 79(13_Supplement). 4925–4925. 1 indexed citations

Jackson-Fisher, Amy, Roberto Gianani, Pamela Whalen, et al.. (2019). Abstract 4035: Protein tyrosine kinase 7 (PTK7) biomarker analysis in patients (pts) treated with PF-06647020, a PTK7 antibody-drug conjugate (ADC), in a phase I dose expansion study. Cancer Research. 79(13_Supplement). 4035–4035. 4 indexed citations

Sachdev, Jasgit C., Michael L. Maitland, Manish Sharma, et al.. (2018). PF-06647020 (PF-7020), an antibody-drug conjugate (ADC) targeting protein tyrosine kinase 7 (PTK7), in patients (pts) with advanced solid tumors: Results of a phase I dose escalation and expansion study.. Journal of Clinical Oncology. 36(15_suppl). 5565–5565. 20 indexed citations

Zhang, Cathy C., Zhengming Yan, Bernadette Pascual, et al.. (2017). Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia. Neoplasia. 20(1). 1–11. 16 indexed citations

Sachdev, Jasgit C., Michael L. Maitland, Monica Sharma, et al.. (2016). A phase 1 study of PF-06647020, an antibody-drug conjugate (ADC) targeting protein tyrosine kinase 7 (PTK7), in patients with advanced solid tumors including platinum resistant ovarian cancer (OVCA). Annals of Oncology. 27. vi570–vi570. 15 indexed citations

Lohse, Ines, Keira Pereira, Stephen S. Chung, et al.. (2015). Co-Injection of patient-derived fibroblasts enhances tumor growth, stromal invasion, and epithelial-to-mesenchymal transition. 4(1). 2–2. 2 indexed citations

10.

Jackson-Fisher, Amy, Pamela Whalen, Mark Elliott, et al.. (2014). Abstract 1958: Interrogating hedgehog pathway and smoothened inhibition by PF-04449913 in patient-derived acute myeloid leukemia models. Cancer Research. 74(19_Supplement). 1958–1958. 5 indexed citations

11.

Fang, Douglas D., Cathy C. Zhang, Yin Gu, et al.. (2013). Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA Mutation. PLoS ONE. 8(6). e67258–e67258. 33 indexed citations

12.

Giddabasappa, Anand, Li D, Peter Olson, et al.. (2013). Contrast agents for quantitative microCT of lung tumors in mice.. PubMed. 63(6). 482–90. 10 indexed citations

13.

Fang, Douglas D., Yin Gu, Konstantinos Tsaparikos, et al.. (2010). Abstract 4483: Establishing patient-derived colorectal cancer stem cell models with a PIK3CA mutation for the development of inhibitory drugs as targeted therapies. Cancer Research. 70(8_Supplement). 4483–4483. 1 indexed citations

14.

Jackson-Fisher, Amy, Gary Bellinger, Jerrica L. Breindel, et al.. (2008). ErbB3 is required for ductal morphogenesis in the mouse mammary gland. Breast Cancer Research. 10(6). R96–R96. 44 indexed citations

15.

Jackson-Fisher, Amy, Gary Bellinger, Elaine Shum, et al.. (2006). Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4. Oncogene. 25(41). 5664–5672. 19 indexed citations

16.

Jackson-Fisher, Amy, Gary Bellinger, Rajani Ramabhadran, et al.. (2004). ErbB2 is required for ductal morphogenesis of the mammary gland. Proceedings of the National Academy of Sciences. 101(49). 17138–17143. 64 indexed citations

17.

Alexander, Diane E., David Kaczorowski, Amy Jackson-Fisher, et al.. (2004). Inhibition of TATA Binding Protein Dimerization by RNA Polymerase III Transcription Initiation Factor Brf1. Journal of Biological Chemistry. 279(31). 32401–32406. 4 indexed citations

18.

Jackson-Fisher, Amy, et al.. (2003). Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proceedings of the National Academy of Sciences. 100(14). 8281–8286. 211 indexed citations

19.

Jackson-Fisher, Amy, et al.. (1999). A Role for TBP Dimerization in Preventing Unregulated Gene Expression. Molecular Cell. 3(6). 717–727. 59 indexed citations

20.

Jackson-Fisher, Amy, Sandeep Burma, Matthew E. Portnoy, et al.. (1999). Dimer Dissociation and Thermosensitivity Kinetics of the Saccharomyces cerevisiae and Human TATA Binding Proteins. Biochemistry. 38(35). 11340–11348. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact